BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12230643)

  • 1. Stroke prevention.
    Sudlow C; Gubitz G; Sandercock P; Lip G
    Clin Evid; 2002 Jun; (7):175-98. PubMed ID: 12230643
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke prevention.
    Sudlow C; Gubitz G; Sandercock P; Lip G
    Clin Evid; 2002 Dec; (8):184-208. PubMed ID: 12603877
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke prevention.
    Lip GY; Rothwell P; Sudlow C
    Clin Evid; 2004 Dec; (12):253-84. PubMed ID: 15865638
    [No Abstract]   [Full Text] [Related]  

  • 4. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on stroke prevention.
    Kenner ME; Kelley RE
    Compr Ther; 2005; 31(2):113-8. PubMed ID: 15901940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of transient ischemic attack or nondisabling stroke related to extracranial internal carotid artery stenosis.
    Kapila V; Jetty P; Basile VS; Dubois L
    CMAJ; 2019 Apr; 191(15):E418-E422. PubMed ID: 30988042
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.
    Dutta M; Hanna E; Das P; Steinhubl SR
    Cerebrovasc Dis; 2006; 22(5-6):331-9. PubMed ID: 16888371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention.
    Freestone B; Lip GY; Rothwell P; Sudlow C
    Clin Evid; 2003 Dec; (10):246-72. PubMed ID: 15555091
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke prevention.
    Gress DR; Singh V
    Phys Med Rehabil Clin N Am; 1999 Nov; 10(4):827-38, viii. PubMed ID: 10573710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient ischemic attack: Part II. Risk factor modification and treatment.
    Simmons BB; Gadegbeku AB; Cirignano B
    Am Fam Physician; 2012 Sep; 86(6):527-32. PubMed ID: 23062044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension: most important risk factor of a stroke].
    Diehm C
    MMW Fortschr Med; 2012 Oct; 154(18):73-4. PubMed ID: 23156880
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?
    Sudlow C
    CMAJ; 2005 Oct; 173(9):1024-6. PubMed ID: 16247094
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical therapy for secondary prevention of stroke.
    Regesta G
    Clin Exp Hypertens; 2002; 24(7-8):555-62. PubMed ID: 12450231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombotic therapy for stroke prevention in patients with atrial fibrillation].
    Tomita F; Kohya T; Kitabatake A
    Nihon Rinsho; 2000 Jun; 58(6):1326-34. PubMed ID: 10879060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
    Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.